Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index global up 0.14% in February, 1.17% year to date

Monday, March 04, 2013
Opalesque Industry Update - The February performance figures for the UCITS Alternative Index Global revealed gains of 0.14% in February, up 1.17% in 2013. The UCITS Alternative Index Funds of Funds does slightly better with a progression of 0.23% and 1.54% for the year. The two best performing strategy indices are the UAI FX and the UAI Long/Short Equity, up respectively 0.56% and 0.40%. They are followed by the UAI Equity Market Neutral and the UAI Emerging Markets (up 0.25% and 0.23%). On the negative side, the UAI CTA loses -0.80%, while the UAI Commodities retraces by -0.40%. With 2.39%, the UAI Long/Short Equity is the best performing strategy index since the beginning of the year.

UAI Blue Chip:
The UCITS Alternative Index Blue Chip declines by -0.15% in February and retraces back to 1.03% for the year. The UAI Blue Chip suffered from losses in its Emerging Markets, Equity and Macro components, only partially offset by gains in its Multi-Strategy, FX and Commodities strategies.

UAIX Indices:
The UAIX indices display mixed results this month. The UAIX Long/Short Equity and the UAIX Multi-Strategy are the best performers with 0.44% and 0.30%. The UAIX Fixed Income Developed Markets rise by 0.09%, while the UAIX Fixed Income Global is up 0.01%. The UAIX CTA, best performer last month, is flat in February. On a year to date basis, the UAIX CTA is up 2.63%, followed by the UAIX Long/Short Equity, up 2.13%, and the UAIX Emerging Markets, up 1.65%.

AUM and number of funds:
In February 2013, the total assets managed by single UCITS hedge funds increased to EUR 143 billion. Fixed Income and Equity funds record the largest inflows. The UCITS Alternative Index is currently composed of more than 870 constituent UCITS hedge funds and funds of hedge funds.

Press release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t